Company Quick10K Filing
Foamix Pharmaceuticals
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$3.02 54 $164
10-Q 2019-09-30 Quarter: 2019-09-30
10-Q 2019-06-30 Quarter: 2019-06-30
10-Q 2019-03-31 Quarter: 2019-03-31
10-K 2018-12-31 Annual: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
20-F 2016-12-31 Annual: 2016-12-31
20-F 2015-12-31 Annual: 2015-12-31
8-K 2019-12-04 Enter Agreement, Exhibits
8-K 2019-11-12 Earnings, Regulation FD, Exhibits
8-K 2019-11-12 Enter Agreement, Other Events, Exhibits
8-K 2019-11-07 Other Events, Exhibits
8-K 2019-09-19 Regulation FD, Exhibits
8-K 2019-09-04 Other Events, Exhibits
8-K 2019-08-19 Enter Agreement, Exhibits
8-K 2019-08-07 Earnings, Regulation FD, Exhibits
8-K 2019-08-05 Other Events, Exhibits
8-K 2019-07-30 Enter Agreement, Off-BS Arrangement, Sale of Shares, Other Events, Exhibits
8-K 2019-05-08 Earnings, Regulation FD, Exhibits
8-K 2019-04-11 Officers, Shareholder Vote, Exhibits
8-K 2019-03-07 Other Events, Exhibits
8-K 2019-02-28 Earnings, Regulation FD, Exhibits
8-K 2019-01-24 Officers, Regulation FD, Exhibits
8-K 2019-01-24 Officers, Regulation FD, Exhibits
8-K 2019-01-03 Officers
8-K 2018-11-19 Officers, Exhibits
8-K 2018-11-07 Earnings, Regulation FD, Other Events, Exhibits
8-K 2018-10-01 Regulation FD, Exhibits
8-K 2018-09-18 Enter Agreement, Exhibits
8-K 2018-09-12 Regulation FD, Other Events, Exhibits
8-K 2018-06-27 Regulation FD, Exhibits
8-K 2018-05-14 Shareholder Vote
8-K 2018-05-09 Earnings, Exhibits
8-K 2018-05-07 Regulation FD, Exhibits
8-K 2018-04-16 Enter Agreement, Exhibits
8-K 2018-03-29 Other Events
8-K 2018-01-29 Other Events
8-K 2018-01-08 Regulation FD, Exhibits
8-K 2018-01-04 Other Events, Exhibits
8-K 2018-01-03 Officers, Other Events, Exhibits

Foamix Pharmaceuticals Financials

-

FOMX Metrics, Comps, Filings


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarter)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Carlisle Companies (CSL) 8,148,590 5,396,700 2,813,500 4,645,400 1,275,900 420,100 712,900 9,740,790
Ashland Global Holdings (ASH) 4,925,340 7,925,000 4,708,000 2,840,000 838,000 104,000 428,000 7,230,340
Univar (UNVR) 3,688,827 7,131,100 5,356,600 8,875,800 0 3,200 347,200 6,715,427
Tilray (TLRY) 1,024,131 663,964 46,039 23,860 -115,063 -107,523 -184,551
Usana Health Sciences (USNA) 1,813,329 532,401 148,245 1,124,796 931,057 108,921 174,953 1,579,064
Raven Industries (RAVN) 1,243,765 376,512 43,057 389,091 124,347 37,982 43,876 1,174,634
Nexeo Solutions (NXEO) 757,054 2,179,100 1,359,600 4,040,400 451,900 19,100 169,200 1,533,454
Innophos Holdings (IPHS) 552,367 870,155 530,968 766,129 137,583 29,005 63,512 850,327
Hawkins (HWKN) 426,308 398,957 175,565 553,862 96,276 25,117 60,860 505,701
Omnova Solutions (OMN) 254,092 570,200 511,500 758,300 175,500 8,200 59,900 540,092
Chromadex (CDXC) 209 44,542 29,397 30,369 20,627 -32,915 -31,409 -9,564
Foamix Pharmaceuticals (FOMX) 146,487 76,226 15,844 2,033 1,725 -63,755 -63,482 107,152
Mediwound (MDWD) 118,500 35,276 0 0 0 0 118,411
Natural Alternatives International (NAII) 73,696 93,490 17,406 72,575 23,575 6,541 11,575 48,656
Mannatech (MTEX) 39,951 67,267 40,022 165,722 132,093 -564 6,596 8,807
Ocean Bio Chem (OBCI) 30,655 37,189 8,469 33,865 14,703 2,875 4,556 31,677
China Jo-Jo Drugstores (CJJD) 36,230 80,218 56,721 110,059 25,553 -2,999 -1,010 20,999
CTI Industries (CTIB) 12,122 35,648 32,201 0 9,299 -7,335 -4,434 12,387
Cyanotech (CYAN) 18,467 33,513 18,409 31,128 12,305 -2,454 -291 24,780
Fuwei Films (FFHL) 6,793 454,682 257,851 303,573 42,152 -8,960 -8,960 -40,115

Balance Sheet ($'000)2014-12-312015-12-312016-12-312017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash43,00818,79531,19016,20613,02011,95288,12728,11819,24439,335
Accounts Receivable4953143,2369968469758891,0661,168308
Inventory
PP&E9101,3211,6062,8522,0452,1662,1573,2192,2972,497
Assets51,277105,245135,63580,25456,46960,074115,187103,73189,55976,226
Accounts Payable6261,3532,2676,4368,18612,3575,3226,3275,6579,434
Long-Term Debt
Liabilities2,5154,4435,65011,65312,12516,17710,12911,54911,56415,844
Stockholders' Equity48,762100,802129,98568,60144,34443,897105,05892,18277,99560,382
Income Statement ($'000)2014-12-312015-12-312016-12-312017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue1,0439069648658603080
Cost of Revenue200
Gross Profit1,041865860
R&D22,82516,84213,14211,66510,84812,556
SG&A3,8012,9093,3093,9945,3446,803
Tax33012015118-1760
Net Income-25,977-18,628-15,480-14,078-15,204-18,993
Cash Flow ($'000)2014-12-312015-12-312016-12-312017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating-23,193-13,329-21,244-10,898-16,642-12,719
Cash Investing20,008-4,69722,034-49,1007,73932,773
Cash Financing016,98175,38112162